These results suggest that the mesothelin-10-5 peptide (AFYPGYLCSL) is naturally processed from mesothelin in pancreatic cancer cells and presented on the cell surface with the HLA-A24 molecule. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.